8 Results for "

Y2-R

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Y2-R" in MCE Product Catalog:

Cat. No.: HY-146486
CAS No.: 2395016-49-4
Purity:  98.09%
Target:  

P2Y Receptor

Research Areas:  

Inflammation/Immunology

P2Y2R/GPR17 antagonist 1 (Compound 14m) is a dual P2Y2R and GPR17 antagonist with IC50 values of 3.17 µM and 1.67 µM against P2Y2R and GPR17, respectively. P2Y2R/GPR17 antagonist 1 shows excellent metabolic stability in human liver microsomes .
loading...
    loading...
Cat. No.: HY-P11043
GEP44 is a peptide biased triple agonist targeting Glucagon-like peptide 1 receptor (GLP-1R), neuropeptide Y1 Receptor (Y1-R), and neuropeptide Y2 Receptor (Y2-R). GEP44 induces Y1-R antagonist-controlled, GLP-1R-dependent stimulation of insulin secretion in both rat and human pancreatic islets by counteracting effects of Y1-R and GLP-1R agonism. GEP44 promotes insulin-independent Y1-R-mediated glucose uptake in muscle tissue and significantly reduces food intake and body weight in diet-induced obese rat models. GEP44 can be used for obesity and type 2 diabetes mellitus research .
loading...
    loading...
Cat. No.: HY-179133
CAS No.: 3021527-82-9
Target:  

P2Y Receptor PKA Raf MEK ERK

Research Areas:  

Inflammation/Immunology

HDB-1 is a selective inhibitor of the P2Y14 receptor (P2Y14R) with an IC50 of 26 pM. HDB-1 shows no significant inhibition on P2Y1R, P2Y2R, P2Y4R, P2Y6R, and P2Y12R. HDB-1 blocks the activation of hepatic stellate cells (HSC) by inhibiting the PKA/Raf1/MEK/ERK signaling pathway mediated by P2Y14R, thereby alleviating the core pathological process of liver fibrosis. HDB-1 can be used for the study of liver fibrosis .
loading...
    loading...
Cat. No.: HY-132240
CAS No.: 824981-55-7
Purity:  99.49%
Research Areas:  

Neurological Disease

SF-22 is a potent and brain-penetrant antagonist of neuropeptide Y receptor (Y2R), with the IC50 value of 750 nM. SF-22 plays an important role in neurological disease .
loading...
    loading...
Cat. No.: HY-P11279
TC2 is an efficient GIPR-preferring monomeric quadruple agonist that can respectively activate GIPR, GLP-1R, GcgR, and Y2R with IC50 values of 0.47, 2.1, 30, and 55 nM respectively. TC2 exhibits a significant GLP-1R preference, with a significant reduction in β-inhibitory protein 2 (βArr2) recruitment, while maintaining a strong cAMP signal. TC2 can be used for research on obesity and diabetes .
loading...
    loading...
Cat. No.: HY-P11044
Research Areas:  

Metabolic Disease

GEP12 is a GLP-1R/Y1-R/Y2-R tri-receptor agonist peptide with an EC50 of 17.3 nM and an IC50 of 19.2 nM for receptor binding. GEP12 may promote glycemic control and weight loss .
loading...
    loading...
Cat. No.: HY-P11275
TC4 is a highly balanced single-molecule quadruple agonist that can respectively activate GIPR, GLP-1R, GcgR, and Y2R with IC50 values of 0.95, 31, 81, and 1100 nM respectively. TC4 exhibits extremely strong signal bias on GLP-1R and has very low recruitment efficacy for β-inhibitor protein 2 (βArr2) and this strong cAMP preference is believed to maximize metabolic benefits (such as weight loss and hypoglycemia) while possibly minimizing side effects mediated by β-inhibitor protein recruitment (such as receptor desensitization). TC4 can be used for research on obesity and diabetes .
loading...
    loading...
Cat. No.: HY-179448
CAS No.: 3120348-70-8
Target:  

P2Y Receptor

Research Areas:  

Cancer

P2Y2R antagonist 1 is a selective P2Y2R antagonist (pIC50 = 7.78). P2Y2R antagonist 1 can be used for the study of Glioma .
loading...
    loading...